Lupeng Pharmaceutical is a biopharmaceutical company focused on developing treatments for hematological malignancies and autoimmune diseases, with notable achievements in BTK inhibitors
Lupeng Pharmaceutical is a biopharmaceutical company focused on developing treatments for hematological malignancies and autoimmune diseases, with notable achievements in BTK inhibitors. It has received approval for rocbrutinib in China and is involved in global clinical trials.